Percutaneous absorption of nicardipine and ketorolac in rhesus monkeys.
Vehicle effects on the percutaneous absorption of nicardipine base, nicardipine hydrochloride, ketorolac acid, and ketorolac tromethamine were determined using the rhesus monkey as an in vivo model for human skin penetration. Vehicles investigated included blends of propylene glycol, trimethylene glycol, ethanol, Azone, Tween 20, water, and long-chain fatty acids. Formulations were prepared such that the compound dose, application area, and percentage saturation of the compound in the vehicle were held constant. Variations in absorption of the compounds were therefore attributable to vehicle effects. Each formulation was applied to three monkeys for a period of 24 hr using 10 Hill Top Chambers. Plasma samples were taken at appropriate intervals for 36 to 48 hr. The results indicated that trimethylene glycol and Tween 20 did not enhance absorption of the test compounds despite claims by other investigators. Azone and ethanol provided moderate enhancement of both the rate and the extent of absorption, while long-chain fatty acids in combination with propylene glycol significantly enhanced penetration. In general, higher fluxes were observed with the more lipophilic compounds nicardipine base and ketorolac acid as compared to the hydrochloride and tromethamine salts.
Yu
D
D
Institute of Pharmaceutical Sciences, Syntex Research, Palo Alto, California 94304.
Sanders
L M
LM
Davidson
G W
GW
Marvin
M J
MJ
Ling
T
T
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000493:pharmacokinetics*; D001682:Biological Availability; D002851:Chromatography, High Pressure Liquid; D020910:Ketorolac; D020911:Ketorolac Tromethamine; D008253:Macaca mulatta; D009529:Nicardipine / Q000493:pharmacokinetics*; D014677:Pharmaceutical Vehicles; D011758:Pyrroles / Q000493:pharmacokinetics*; D012869:Skin Absorption; D012995:Solubility; D014046:Tolmetin / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D014325:Tromethamine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D014677:Pharmaceutical Vehicles; D011758:Pyrroles; D014325:Tromethamine; D020911:Ketorolac Tromethamine; D009529:Nicardipine; D014046:Tolmetin; D020910:Ketorolac